Atlas Trials

Kronos Bio

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Kronos Bio

RecordFirmDate
A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05028751)Kronos Bio2022-08-05
Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML (NCT05020665)Kronos Bio2021-11-24
A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC) (NCT04718675)Kronos Bio2021-02-08

Track Kronos Bio automatically

Every clearance here is in the API, with alerts when new ones post.